Autopsies suggest COVID’s smell loss is caused by inflammation, not virus

Although the loss of smell and taste became apparent symptoms of COVID-19 early in the pandemic, researchers are still working out why that happens—is the virus directly infecting and destroying the cells responsible for these critical senses, or is it collateral damage from our immune systems fighting off the invading foe?

According to a postmortem study out this week in JAMA Neurology, it’s the latter. The study—which dove deep into the noses, nerves, and brains of 23 people who died of COVID-19—is the most detailed look at the coronavirus’ effects on our sniffers. Researchers concluded that inflammation—not the virus—is behind the loss of smell and taste during a bout of COVID-19, which is good news in some ways. It suggests that treatments with anti-inflammatory drugs could prevent severe or long-term damage to those critical senses.

The finding follows a mix of data on the effects of SARS-CoV-2 on our sense of smell. Some data suggested that the virus can infect the nerves that carry smells signals to our brain—olfactory neurons. Thus, the lost senses could be caused by direct infections. But others found that the virus wasn’t present in those neurons at death.

For the new study, researchers led by pathologist Cheng-Ying Ho of Johns Hopkins University closely examined olfactory tissue from 23 patients who died with COVID-19—nine of whom had completely or partially lost senses of smell and taste. Specifically, the researchers examined olfactory neurons in the nasal mucosa, blood vessels, and the number of olfactory axons—which are parts of neurons that transmit electrical signals—in each patient. They also examined injuries to the olfactory bulb, the part of the brain where smell signals are received, and determined whether SARS-CoV-2 was present or not.

They compared the findings to those from 14 people who died of other causes and were not infected with COVID-19 and did not have any loss of smell or taste.

Following the scent

Compared with controls and COVID-19 patients without altered smell and taste, the COVID-19 patients who had altered senses of smell and taste had more injuries to their nasal mucosa, more damage to their vasculature, and significantly fewer olfactory axons.

However, that damage to the olfactory tissue wasn’t linked to the documented severity of the patients’ COVID-19 infections—some people who had mild COVID-19 infections had severe injuries to their olfactory bulbs, for instance. In addition, only three of the 23 patients had detectable levels of SARS-CoV-2 genetic material present in their olfactory bulbs. Of those three, only one had reported a loss of smell. The other two reported no loss of taste or smell. These results suggest “olfactory pathology was not caused by direct viral injury,” the authors concluded.

“Previous investigations that only relied on routine pathological examinations of tissue —and not the in-depth and ultrafine analyses we conducted—surmised that viral infection of the olfactory neurons and olfactory bulb might play a role in loss of smell associated with COVID-19,” Ho said in a statement. “But our findings suggest that SARS-CoV-2 infection of the olfactory epithelium leads to inflammation, which in turn, damages the neurons, reduces the numbers of axons available to send signals to the brain and results in the olfactory bulb becoming dysfunctional.”

This dysfunction can be so severe that loss of smell and taste could persist for long periods or cause permanent damage. But, Ho noted in an audio interview, “if inflammation is the major cause of the injury in olfactory structures, it is possible that we might be able to use anti-inflammatory agent as the treatment,” she said. “That’s what I hope that our study can inspire—future studies to look into this.”